Prognostic implication of types of tumor-associated macrophages in Hodgkin lymphoma

Virchows Archiv

Volumn 459, Issue 4, 2011, Pages 361-366

  Zaki, Mona A A ^a   Wada, Naoki ^a   Ikeda, Junichiro ^a   Shibayama, Hirohiko ^a   Hashimoto, Koji ^b   Yamagami, Tamotsu ^c   Tatsumi, Yoichi ^d   Tsukaguchi, MacHiko ^e   Take, Hironori ^f   Tsudo, Mitsuru ^g   Morii, Eiichi ^a   Aozasa, Katsuyuki ^a  

^a OSAKA UNIVERSITY   (Japan)

^b KANSAI ROSAI HOSPITAL   (Japan)

^c OSAKA POLICE HOSPITAL   (Japan)

^d KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e SAKAI MUNICIPAL HOSPITAL   (Japan)

^f TOYONAKA MUNICIPAL HOSPITAL   (Japan)

^g OSAKA RED CROSS HOSPITAL   (Japan)

Author keywords

Double staining; Hodgkin lymphoma; Immunohistochemistry; M1 type; M2 type; Prognosis; Tumor associated macrophages

Indexed keywords

BLEOMYCIN; CD163 ANTIGEN; CHLORDANE; DACARBAZINE; DOXORUBICIN; HLA DR ANTIGEN; VINBLASTINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER SURVIVAL; CELL TYPE; FEMALE; FOLLOW UP; HODGKIN DISEASE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; SEX DIFFERENCE; SURVIVAL TIME; TUMOR ASSOCIATED LEUKOCYTE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HODGKIN DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MACROPHAGES; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; YOUNG ADULT;

EID: 80855130756     PISSN: 09456317     EISSN: 14322307     Source Type: Journal    
DOI: 10.1007/s00428-011-1140-8     Document Type: Article

References (18)

1. C Fermé H Eghbali JH Meerwaldt C Rieux J Bosq F Berger T Girinsky P Brice MB van't Veer JA Walewski P Lederlin U Tirelli P Carde E Van den Neste E Gyan M Monconduit M Diviné JM Raemaekers G Salles EM Noordijk GJ Creemers J Gabarre A Hagenbeek O Reman M Blanc J Thomas B Vié JC Kluin-Nelemans F Viseu JW Baars P Poortmans PJ Lugtenburg C Carrie J Jaubert M Henry-Amar 2007 Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease N Engl J Med 357 1916 1927 17989384 10.1056/NEJMoa064601 (Pubitemid 350074687)
2. SM Ansell JO Armitage 2006 Management of Hodgkin lymphoma Mayo Clin Proc 81 419 426 16529147 10.4065/81.3.419 (Pubitemid 43334638)
3. CE Lewis JW Pollard 2006 Distinct role of macrophages in different tumor microenvironments Cancer Res 66 605 612 16423985 10.1158/0008-5472.CAN-05-4005 1:CAS:528:DC%2BD28XlsFOmtw%3D%3D (Pubitemid 43165918)
4. C Steidl T Lee SP Shah P Farinha G Han T Nayar A Delaney SJ Jones J Iqbal DD Weisenburger MA Bast A Rosenwald HK Muller-Hermelink LM Rimsza E Campo J Delabie RM Braziel JR Cook RR Tubbs ES Jaffe G Lenz JM Connors LM Staudt WC Chan RD Gascoyne 2010 Tumor-associated macrophages and survival in classic Hodgkin's lymphoma N Engl J Med. 362 875 885 20220182 10.1056/NEJMoa0905680 1:CAS:528:DC%2BC3cXjt1yls7Y%3D
5. EP Buddingh ML Kuijjer RA Duim H Bürger K Agelopoulos O Myklebost M Serra F Mertens PC Hogendoorn AC Lankester AM Cleton-Jansen 2011 Tumor-infiltrating macrophages are associated with metastasis suppression in high-grade osteosarcoma: a rationale for treatment with macrophage activating agents Clin Cancer Res. 17 2110 2119 21372215 10.1158/1078-0432.CCR-10-2047 1:CAS:528:DC%2BC3MXkslCgsL4%3D
6. F Dai L Liu G Che N Yu Q Pu S Zhang J Ma L Ma Z You 2010 The number and microlocalization of tumor-associated immune cells are associated with patient's survival time in non-small cell lung Cancer BMC Cancer 10 220 20487543 10.1186/1471-2407-10-220 Available at: http://www.biomedcentral.com/1471-2407/ 10/220
7. TO Jensen H Schmidt HJ Møller M Høyer MB Maniecki P Sjoegren IJ Christensen T Steiniche 2009 Macrophage markers in serum and tumor have prognostic impact in American Joint Committee on Cancer stage I/II melanoma J Clin Oncol 7 3330 3337 10.1200/JCO.2008.19.9919
8. J Ma L Liu G Che N Yu F Dai Z You 2010 The M1 form of tumor-associated macrophages in non-small cell lung cancer is positively associated with survival time BMC Cancer 10 112 20338029 10.1186/1471-2407-10-112 Available at: http://www.biomedcentral.com/1471-2407/10/112
9. SL Glaser JL Hsu 2002 Hodgkin's disease in Asians: incidence patterns and risk factors in population-based data Leuk Res 26 261 269 11792415 10.1016/S0145-2126(01)00126-6 (Pubitemid 34037023)
10. K Aozasa T Ueda M Tamai T Tsujimura 1986 Hodgkin's disease in Osaka, Japan (1964-1985) Eur J Cancer Clin Oncol 22 1117 1119 3780817 10.1016/0277-5379(86)90016-7 1:STN:280:DyaL2s%2FlsVWltA%3D%3D (Pubitemid 16017150)
11. JW Tjiu JS Chen CT Shun SJ Lin YH Liao CY Chu TF Tsai HC Chiu YS Dai H Inoue PC Yang ML Kuo SH Jee 2009 Tumor-associated macrophage-induced invasion and angiogenesis of human basal cell carcinoma cells by cyclooxygenase-2 induction J Invest Dermatol 129 1016 1025 18843292 10.1038/jid.2008.310 1:CAS:528:DC%2BD1MXjs1KhsLY%3D
12. C Lamagna M Aurrand-Lions BA Imhof 2006 Dual role of macrophages in tumor growth and angiogenesis J Leuk Biol 80 705 713 10.1189/jlb.1105656 1:CAS:528:DC%2BD28XhtV2hsLzO (Pubitemid 44835885)
13. B Al-Sarireh O Eremin 2004 Tumor-associated macrophages (TAMS): disordered function, immune suppression and progressive tumour growth J R Coll Surg Edinb 5 1 16 (Pubitemid 35385843)
14. C Caux B Vanbervliet C Massacrier C Dezutter-Dambuyant B de Saint-Vis C Jacquet K Yoneda S Imamura D Schmitt J Banchereau 1996 CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF + TNF alpha J Exp Med 184 695 706 8760823 10.1084/jem.184.2.695 1:CAS:528:DyaK28XltVCrsb0%3D (Pubitemid 26324123)
15. H Nakamura H Saji I Aute N Kawasaki M Hosaka A Ogata T Saijo H Kato 2003 Peripheral leukocytes with HLA-DR+/CD8-phenotype are associated with prognosis in patients with lung cancer Anticancer Res 23 4149 4152 14666616 (Pubitemid 37474911)
16. MB Maniecki HJ Møller SK Moestrup BK Møller 2006 CD163 positive subsets of blood dendritic cells: the scavenging macrophage receptors CD163 and CD91 are coexpressed on human dendritic cells and monocytes Immunobiology 211 407 417 16920480 10.1016/j.imbio.2006.05.019 1:CAS:528:DC%2BD28XhtVGlsr3L
17. P Kamper K Bendix S Hamilton-Dutoit B Honoré JR Nyengaard F d'Amore 2011 Tumor-infiltrating macrophages correlate with adverse prognosis and Epstein-Barr virus status in classical Hodgkin's lymphoma Haematologica 96 269 276 21071500 10.3324/haematol.2010.031542
18. CH Lee I Espinosa S Vrijaldenhoven S Subramanian KD Montgomery S Zhu, et al. 2008 Prognostic significance of macrophage infiltration in leiomyosarcomas Clin Cancer Res 14 1423 1430 18316565 10.1158/1078-0432.CCR-07-1712 1:CAS:528:DC%2BD1cXislSrsL0%3D (Pubitemid 351413925)